source,curated_field
2L_TREATMENT,treatment_name
2L_TREATMENT,treatment_reason
3L_TREATMENT,treatment_name
3L_TREATMENT,treatment_reason
ABLATION_EMBOLIZATION_TX_ADJUVANT,treatment_reason
ABLATION_EMBOLIZATION_TX_ADJUVANT,treatment_type
ADC+IMMUNOTHERAPY,treatment_type
ADC_THERAPY,treatment_type
ADENOCARCINOMA_SUBTYPE_WHO2015,cancer_subtype
ADJ_XRT,treatment_reason
ADJ_XRT,treatment_type
ADJUVANT,treatment_reason
ADJUVANT_CHEMO,treatment_name
ADJUVANT_CHEMO,treatment_reason
ADJUVANT_CHEMO,treatment_type
ADJUVANT_CHEMO_REGIMEN,treatment_name
ADJUVANT_CHEMO_REGIMEN,treatment_reason
ADJUVANT_CHEMO_REGIMEN,treatment_type
ADJUVANT_CHEMOTHERAPY,treatment_reason
ADJUVANT_CHEMOTHERAPY,treatment_type
ADJUVANT_CT,treatment_reason
ADJUVANT_CT,treatment_type
ADJUVANT_CYCLES_NUM,treatment_number
ADJUVANT_HORMONE_THERAPY,treatment_name
ADJUVANT_HORMONE_THERAPY,treatment_reason
ADJUVANT_HORMONE_THERAPY,treatment_type
ADJUVANT_IMMUNOTHERAPY,treatment_reason
ADJUVANT_IMMUNOTHERAPY,treatment_type
ADJUVANT_RADIATION_THERAPY,treatment_reason
ADJUVANT_RADIATION_THERAPY,treatment_type
ADJUVANT_TARGETED,treatment_reason
ADJUVANT_TARGETED,treatment_type
ADJUVANT_THERAPY,treatment_reason
ADJUVANT_TX,treatment_reason
ADJUVANT_TX,treatment_type
ADJUVANT_XRT,treatment_reason
ADJUVANT_XRT,treatment_type
ADMINISTRATION_OF_DRUG_WEEKS,treatment_duration
AGE,age_at_procurement
AGE_AT_CHEMOTHERAPY_START,treatment_end
AGE_AT_CHEMOTHERAPY_START,treatment_notes
AGE_AT_CHEMOTHERAPY_START,treatment_start
AGE_AT_CHEMOTHERAPY_START,treatment_type
AGE_AT_CHEMOTHERAPY_STOP,treatment_end
AGE_AT_CHEMOTHERAPY_STOP,treatment_notes
AGE_AT_CHEMOTHERAPY_STOP,treatment_start
AGE_AT_CHEMOTHERAPY_STOP,treatment_type
AGE_AT_DEATH,age_at_death
AGE_AT_DERIVATION,age_at_procurement
AGE_AT_DIAGNOSIS,age_at_diagnosis
AGE_AT_DOS_BX,age_at_procurement
AGE_AT_DX,age_at_diagnosis
AGE_AT_EVIDENCE_OF_METS,age_at_metastasis
AGE_AT_INITIAL_DIAGNOSIS,age_at_diagnosis
AGE_AT_INITIAL_PATHOLOGIC_DIAGNOSIS,age_at_diagnosis
AGE_AT_MET,age_at_metastasis
AGE_AT_METS,age_at_metastasis
AGE_AT_PD1,age_at_diagnosis
AGE_AT_PROCUREMENT,age_at_procurement
AGE_AT_RADIATION_START,treatment_end
AGE_AT_RADIATION_START,treatment_notes
AGE_AT_RADIATION_START,treatment_start
AGE_AT_RADIATION_START,treatment_type
AGE_AT_RADIATION_STOP,treatment_end
AGE_AT_RADIATION_STOP,treatment_notes
AGE_AT_RADIATION_STOP,treatment_start
AGE_AT_RADIATION_STOP,treatment_type
AGE_AT_RESECTION,age_at_procurement
AGE_AT_SAMPLE_COLLECTION,age_at_procurement
AGE_AT_SAMPLING,age_at_procurement
AGE_AT_SCC,age_at_procurement
AGE_AT_SEQ_REPORT,age_at_procurement
AGE_AT_SEQ_REPORTED_YEARS,age_at_procurement
AGE_AT_SEQUENCING,age_at_procurement
AGE_AT_SPECIMEN_ACQUISITION,age_at_procurement
AGE_AT_TCGA_SPECIMEN,age_at_procurement
AGE_D,age_at_diagnosis
AGE_IN_DAYS,age_at_procurement
AGE_RESECTED,age_at_procurement
AGE_START_IO,age_at_procurement
AGE_TESTING_YEARS,age_at_procurement
AGE_YRS,age_at_procurement
AGENT,treatment_dose
AGENT,treatment_name
ALKYLATING_AGENT,treatment_type
ALKYLATING_CHEMOTHERAPY,treatment_type
ALKYLATING_TX,treatment_type
ALL_TX_AT_MSK,treatment_notes
ALPELISIB_DOSE,treatment_dose
ALPELISIB_DOSE,treatment_name
ALPELISIB_SCHEDULING,treatment_frequency
ALPELISIB_SCHEDULING,treatment_name
ALTERNATE_THERAPY,treatment_status
ALTERNATE_THERAPY,treatment_type
ALTERNATE_THERAPY_OTHER,treatment_name
ALTERNATE_THERAPY_OTHER,treatment_notes
ALTERNATE_THERAPY_OTHER,treatment_reason
ALTERNATE_THERAPY_OTHER,treatment_status
ALTERNATE_THERAPY_OTHER,treatment_type
ANATOMICAL_SUBTYPE,body_site
ANCESTRY_PRIMARY,ancestry
ANCESTRY_PRIMARY,ancestry_details
ANDROGEN_DEPRIVATION_THERAPY,treatment_name
ANDROGEN_DEPRIVATION_THERAPY,treatment_type
ANTHRACYCLINE_TX,treatment_name
ANTIMETABOLITE_TX,treatment_type
ANY_LINE_CHEMO,treatment_type
ANY_LINE_HORMONE,treatment_type
ANY_LINE_IMMUNO,treatment_type
ANY_LINE_IODINE,treatment_name
ANY_LINE_NTRK,treatment_type
ANY_LINE_TARGETED,treatment_type
ANY_THERAPY_2YRS,treatment_duration
ANYTIME_CANCER_LOC_OVARY,sex
BIOPSY_SITE,body_site
BIRTH_COUNTRY,country
BRACHYTHERAPY_TOTAL_DOSE_POINT_A,treatment_dose
BRACHYTHERAPY_TOTAL_DOSE_POINT_A,treatment_notes
BRACHYTHERAPY_TOTAL_DOSE_POINT_A,treatment_type
BRACHYTHERAPY_TYPE,treatment_name
BRACHYTHERAPY_TYPE,treatment_type
BRACHYTHERAPY_TYPE_OTHER,treatment_name
BRACHYTHERAPY_TYPE_OTHER,treatment_type
BREAST_SURGERY,treatment_name
BREAST_SURGERY,treatment_type
CALC_TREATMENT_NAIVE,treatment_notes
CALC_TREATMENT_NAIVE,treatment_status
CANCER.TYPE,cancer_type
CANCER_SUBTYPE_CURATED,cancer_subtype
CANCER_TYPE,cancer_type
CANCER_TYPE_DETAILED,cancer_type_details
CARBOPLATIN_TX,treatment_name
CERVIX_SUV_RESULTS,sex
CHEMO_CONCURRENT_COURSE,treatment_frequency
CHEMO_CONCURRENT_COURSE,treatment_status
CHEMO_CONCURRENT_COURSE,treatment_type
CHEMO_CONCURRENT_DOSE,treatment_dose
CHEMO_CONCURRENT_DOSE,treatment_number
CHEMO_CONCURRENT_DOSE,treatment_status
CHEMO_CONCURRENT_DOSE,treatment_type
CHEMO_CONCURRENT_FRACTIONS_TOTAL,treatment_dose
CHEMO_CONCURRENT_FRACTIONS_TOTAL,treatment_number
CHEMO_CONCURRENT_FRACTIONS_TOTAL,treatment_status
CHEMO_CONCURRENT_FRACTIONS_TOTAL,treatment_type
CHEMO_CONCURRENT_REASON_NOT_GIVEN,treatment_notes
CHEMO_CONCURRENT_REASON_NOT_GIVEN,treatment_type
CHEMO_CONCURRENT_REASON_NOT_OTHER,treatment_notes
CHEMO_CONCURRENT_REASON_NOT_OTHER,treatment_type
CHEMO_CONCURRENT_TYPE,treatment_name
CHEMO_CONCURRENT_TYPE,treatment_status
CHEMO_CONCURRENT_TYPE,treatment_type
CHEMO_CONCURRENT_TYPE_OTHER,treatment_name
CHEMO_CONCURRENT_TYPE_OTHER,treatment_status
CHEMO_CONCURRENT_TYPE_OTHER,treatment_type
CHEMO_CYCLES,treatment_number
CHEMO_CYCLES,treatment_type
CHEMO_DETAILS,treatment_name
CHEMO_DETAILS,treatment_type
CHEMO_FIRST_LINE,treatment_name
CHEMO_FIRST_LINE,treatment_reason
CHEMO_FIRST_LINE,treatment_status
CHEMO_FIRST_LINE,treatment_type
CHEMO_OTHER,treatment_name
CHEMO_OTHER,treatment_type
CHEMO_OTHER_CYCLES,treatment_dose
CHEMO_OTHER_CYCLES,treatment_duration
CHEMO_OTHER_CYCLES,treatment_notes
CHEMO_OTHER_CYCLES,treatment_number
CHEMO_OTHER_CYCLES,treatment_type
CHEMO_REGIMEN_CATEGORY,treatment_group
CHEMO_REGIMEN_CATEGORY,treatment_name
CHEMO_REGIMEN_CATEGORY,treatment_notes
CHEMO_REGIMEN_CATEGORY,treatment_reason
CHEMO_REGIMEN_CATEGORY,treatment_type
CHEMO_TX,treatment_type
CHEMOTHERAPY,treatment_name
CHEMOTHERAPY,treatment_type
CHEMOTHERAPY+IMMUNOTHERAPY,treatment_type
CHEMOTHERAPY_AGENTS,treatment_name
CHEMOTHERAPY_AGENTS,treatment_type
CHEMOTHERAPY_PRIOR_SAMPLE_ACQUIRED,treatment_name
CHEMOTHERAPY_PRIOR_SAMPLE_ACQUIRED,treatment_type
CHEMOTHERAPY_TYPE,treatment_notes
CHEMOTHERAPY_TYPE,treatment_type
CHRONIC_HEPATITIS_ANY_TYPE,cancer_subtype
CISPLATIN_TX,treatment_name
CLAUDIN_SUBTYPE,cancer_subtype
CLINICAL_STATUS_AT_COLLECTION_EVENT,vital_status
CNS_DISEASE,disease
COMPLETED_RADIATION_DOSE,treatment_dose
COMPLETED_RADIATION_DOSE,treatment_status
COMPLETED_TOTAL_RADIATION_DOSE,treatment_dose
COMPLETED_TOTAL_RADIATION_DOSE,treatment_status
COMPLETED_TOTAL_RADIATION_DOSE,treatment_type
CONCURRENT_CHEMOTHERAPY,treatment_status
CONCURRENT_CHEMOTHERAPY,treatment_type
COUNTRY,country
COUNTRY_OF_ORIGIN,country
COUNTRY_OF_PROCUREMENT,country
CRDB_PRIOR_RX,treatment_notes
CRDB_PRIOR_RX,treatment_status
CRDB_SURVIVAL_STATUS,vital_status
CRDB_TREATMENT_END_DAYS,treatment_end
CRDB_TREATMENT_END_DAYS,treatment_notes
CRT_CHEMOAGENT,treatment_name
CRT_CHEMOAGENT,treatment_type
CUMULATIVE_CHEMO,treatment_notes
CUMULATIVE_CHEMO,treatment_type
CUMULATIVE_TREATMENT_REGIMEN_COUNT,treatment_notes
CUMULATIVE_TREATMENT_REGIMEN_COUNT,treatment_number
CUMULATIVE_TREATMENT_REGIMENS,treatment_dose
CUMULATIVE_TREATMENT_REGIMENS,treatment_name
CUMULATIVE_TREATMENT_STAGE_COUNT,treatment_notes
CUMULATIVE_TREATMENT_STAGE_COUNT,treatment_number
CUMULATIVE_TREATMENT_STAGES,treatment_reason
CUMULATIVE_TREATMENT_STAGES,treatment_status
CUMULATIVE_TREATMENT_TYPE_COUNT,treatment_notes
CUMULATIVE_TREATMENT_TYPE_COUNT,treatment_number
CUMULATIVE_TREATMENT_TYPES,treatment_type
curated_cancer_type,sex
CURRENT_CYCLE,treatment_status
CURRENT_REGIMEN,treatment_name
CURRENT_REGIMEN,treatment_reason
CURRENT_REGIMEN,treatment_status
CYCLES_COMPLETED,treatment_number
CYCLES_COMPLETED,treatment_status
CYCLES_ON_THERAPY,treatment_notes
CYCLES_ON_THERAPY,treatment_number
CYTOLOGICAL_PHENOTYPE,cancer_subtype
CYTOTOXIC_TREATMENT,treatment_type
CYTOTOXIC_TX,treatment_type
DEFINITIVE_SURGICAL_PROCEDURE,treatment_name
DEFINITIVE_SURGICAL_PROCEDURE,treatment_type
DETAILED_CANCER_TYPE,cancer_type_details
DETAILED_PRIMARY_SITE,body_site
DETAILS_FIRST_LINE_COMMENTS,treatment_group
DETAILS_FIRST_LINE_COMMENTS,treatment_name
DETAILS_FIRST_LINE_COMMENTS,treatment_notes
DETAILS_FIRST_LINE_COMMENTS,treatment_reason
DFS_STATUS,vital_status
DIABETES_DIAGNOSIS_INDICATOR,disease
DIAGNOSIS,disease
DIAGNOSIS.AGE,age_at_diagnosis
DIAGNOSIS_CANCER_BONE,body_site
DIAGNOSIS_CANCER_LOC_AXILLARY_LN,body_site
DIAGNOSIS_CANCER_LOC_BRAIN,body_site
DIAGNOSIS_CANCER_LOC_BREAST,body_site
DIAGNOSIS_CANCER_LOC_CHEST_WALL,body_site
DIAGNOSIS_CANCER_LOC_LIVER,body_site
DIAGNOSIS_CANCER_LOC_LUNG,body_site
DIAGNOSIS_CANCER_LOC_OTHER_LN,body_site
DIAGNOSIS_CANCER_LOC_OVARY,body_site
DIAGNOSIS_CANCER_LOC_OVARY,sex
DIAGNOSIS_CANCER_LOC_PLEURAL_EFFUSION,body_site
DIAGNOSIS_CANCER_LOC_SKIN,body_site
DISEASE,disease
DISEASE_CODE,disease
DISEASE_EXTENT,body_site
DISEASE_EXTENT,disease
DISEASE_MULTIFOCAL_INDICATOR,body_site
DISEASE_ONTOLOGY,disease
DMETS_DX_FEMALE_GENITAL,sex
DMETS_DX_MALE_GENITAL,sex
DMETS_DX_OVARY,sex
DOMINANT_HISTOLOGICAL_SUBTYPE,cancer_subtype
DOPAMINE,treatment_name
DOSE_MG_DAY_STEROID_DURING_PD1,treatment_dose
DOSE_MG_DAY_STEROID_DURING_PD1,treatment_frequency
DOSE_MG_DAY_STEROID_DURING_PD1,treatment_status
DOSE_MG_DAY_STEROID_DURING_PD1,treatment_type
DOSE_MG_DAY_STEROID_PD1_START,treatment_dose
DOSE_MG_DAY_STEROID_PD1_START,treatment_frequency
DOSE_MG_DAY_STEROID_PD1_START,treatment_type
DOSE_OF_PEMBROLIZUMAB_PER_INJECTION (MG/KG),treatment_dose
DOSE_OF_PEMBROLIZUMAB_PER_INJECTION (MG/KG),treatment_name
DOSE_OF_RE-IRRADIATION,treatment_dose
DOSE_OF_RE-IRRADIATION,treatment_end
DOSE_OF_RE-IRRADIATION,treatment_notes
DOSE_OF_RE-IRRADIATION,treatment_number
DOSE_OF_RE-IRRADIATION,treatment_start
DOSE_OF_RE-IRRADIATION,treatment_status
DOSE_OF_RE-IRRADIATION,treatment_type
DOT_MONTHS,treatment_duration
DRUG,treatment_name
DRUG_AND_DOSE_STEROID_DURING_PD1,treatment_name
DRUG_AND_DOSE_STEROID_DURING_PD1,treatment_status
DRUG_AND_DOSE_STEROID_DURING_PD1,treatment_type
DRUG_LAST_ADMIN,treatment_end
DRUG_LAST_ADMIN,treatment_start
DRUG_START,treatment_end
DRUG_START,treatment_start
DRUG_TYPE,treatment_type
DSS_STATUS,vital_status
DURATION_OF_INDUCTION_TREATMENT,treatment_duration
DURATION_OF_INDUCTION_TREATMENT,treatment_reason
DURATION_OF_THERAPY_DAYS,treatment_duration
DURATION_OF_THERAPY_WEEKS,treatment_duration
DX_AT_INCLUSION,cancer_type
DX_ORG_INST,cancer_type_details
DX_TYPE,treatment_name
DX_TYPE,treatment_notes
DX_TYPE,treatment_type
ENDOCRINE_THERAPY,treatment_name
ENDOCRINE_THERAPY,treatment_type
EPINEPHRINE,treatment_name
ESOPHAGEAL_TUMOR_LOCATION_CENTERED,body_site
ESOPHAGEAL_TUMOR_LOCATION_INVOLVED,body_site
ETHNICITY,ancestry
ETHNICITY,ancestry_details
ETHNICITY_SELF_IDENTIFY,ancestry
ETHNICITY_SELF_IDENTIFY,ancestry_details
EXTRANODAL_DISEASE,disease
FAMILY_HISTORY_TESTICULAR_CANCER,sex
FIFTH_LINE,treatment_name
FIFTH_LINE,treatment_number
FIFTH_LINE,treatment_reason
FIFTH_LINE,treatment_status
FIRST_LINE_MET_TX,treatment_name
FIRST_LINE_MET_TX,treatment_reason
FIRST_LINE_THERAPY,treatment_group
FIRST_LINE_THERAPY,treatment_name
FIRST_LINE_THERAPY,treatment_reason
FIRST_LINE_TREATMENT,treatment_name
FIRST_LINE_TREATMENT,treatment_reason
FIRST_SURGICAL_PROCEDURE_OTHER,treatment_name
FIRST_SURGICAL_PROCEDURE_OTHER,treatment_status
FIRST_SURGICAL_PROCEDURE_OTHER,treatment_type
FIRST_THERAPY,treatment_status
FIRST_THERAPY,treatment_type
FIRSTLINE_CHEMO_GROUP,treatment_group
FIRSTLINE_CHEMO_GROUP,treatment_name
FIRSTLINE_CHEMO_GROUP,treatment_type
FOLIC_ACID_TX,treatment_name
FORMULATION,treatment_dose
FORMULATION,treatment_name
FORMULATION,treatment_notes
FORMULATION,treatment_status
FOURTH_LINE,treatment_name
FOURTH_LINE,treatment_reason
FOURTH_LINE,treatment_type
GASTRIC_CLASSIFICATION,cancer_subtype
GENDER,sex
GYN_DIAGNOSIS_CHEMO_INTENT_DESCRIPTION,treatment_notes
GYN_DIAGNOSIS_CHEMO_INTENT_DESCRIPTION,treatment_type
GYN_DIAGNOSIS_HISTOLOGY,cancer_type_details
HAD_SURGERY,treatment_type
HEPATECTOMY,treatment_name
HEPATECTOMY,treatment_type
HER2_VITAL_STATUS,vital_status
HISPANIC,ancestry
HISPANIC,ancestry_details
HIST_SUBTYPE1,cancer_subtype
HIST_SUBTYPE2,cancer_subtype
HISTOLOGICAL_DIAGNOSIS,cancer_type_details
HISTOLOGICAL_SUBTYPE,cancer_subtype
HISTOLOGICAL_TYPE,cancer_type_details
HISTOLOGY_DIAGNOSIS,cancer_type
HISTOLOGY_SUBTYPE,cancer_subtype
HISTORY_HORMONAL_CONTRACEPTIVES_USE,treatment_status
HISTORY_HORMONAL_CONTRACEPTIVES_USE,treatment_type
HISTORY_IMMUNOSUPPRESIVE_DX,treatment_name
HISTORY_IMMUNOSUPPRESIVE_DX,treatment_status
HISTORY_IMMUNOSUPPRESIVE_DX,treatment_type
HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER,treatment_name
HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER,treatment_status
HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER,treatment_type
HISTORY_IONIZING_RT_TO_HEAD,treatment_notes
HISTORY_IONIZING_RT_TO_HEAD,treatment_status
HISTORY_IONIZING_RT_TO_HEAD,treatment_type
HISTORY_MENOPAUSAL_HORMONE_THERAPY,treatment_status
HISTORY_MENOPAUSAL_HORMONE_THERAPY,treatment_type
HISTORY_NEOADJUVANT_MEDICATION,treatment_reason
HISTORY_NEOADJUVANT_MEDICATION,treatment_type
HISTORY_NEOADJUVANT_STEROID_TX,treatment_reason
HISTORY_NEOADJUVANT_STEROID_TX,treatment_type
HISTORY_NEOADJUVANT_TRTYN,treatment_reason
HISTORY_NEOADJUVANT_TRTYN,treatment_status
HISTORY_NEOADJUVANT_TRTYN,treatment_type
HISTORY_NEOADJUVANT_TX_TYPE,treatment_reason
HISTORY_NEOADJUVANT_TX_TYPE,treatment_type
HISTORY_OF_UNDESCENDED_TESTIS,sex
HISTORY_REFLUX_DISEASE_TREATMENT,treatment_notes
HISTORY_REFLUX_DISEASE_TREATMENT,treatment_status
HISTORY_REFLUX_DISEASE_TREATMENT,treatment_type
HORMONE_THERAPY,treatment_type
HYPERTENSION_DIAGNOSIS,disease
HYSTERECTOMY_TYPE,treatment_name
HYSTERECTOMY_TYPE,treatment_type
ICI,treatment_name
IFN_TX_90_DAYS_PRIOR_TO_RESECTION,treatment_status
IFN_TX_90_DAYS_PRIOR_TO_RESECTION,treatment_type
IHC_SUBTYPE,cancer_subtype
IMMUNE_TREATMENT,treatment_name
IMMUNE_TREATMENT,treatment_reason
IMMUNE_TREATMENT,treatment_type
IMMUNOSUPPRESSION,treatment_name
IMMUNOSUPPRESSION,treatment_type
IMMUNOTHERAPY,treatment_type
INCIDENTAL_PROSTATE_CANCER,cancer_type
INCIDENTAL_PROSTATE_CANCER,sex
INDUCTION,treatment_name
INDUCTION,treatment_reason
INFERRED_ETHNICITY,ancestry
INFERRED_ETHNICITY,ancestry_details
INITIAL_DIAGNOSIS_OF_RECURRENT_TUMORS,cancer_type_details
INITIAL_DIAGNOSIS_TYPE,disease
INITIAL_RX,treatment_dose
INITIAL_RX,treatment_name
INITIAL_RX,treatment_number
INITIAL_RX,treatment_status
INITIAL_TREATMENT,treatment_reason
INITIAL_TREATMENT,treatment_status
INITIAL_TREATMENT,treatment_type
INTEGRATED_PHENOTYPE,cancer_subtype
INTERFERON_ALPHA,treatment_name
INTESTINAL_TYPE_SUBCLASS,cancer_subtype
INTRAVESICAL_TREATMENT,treatment_type
INVASIVE_CARCINOMA_DX_AGE,age_at_diagnosis
IO_DRUG,treatment_name
IO_DRUG,treatment_type
IO_LINE,treatment_reason
IO_LINE,treatment_type
IO_REGIMEN_MONOTHERAPY_VS_COMBINATION,treatment_type
IO_THERAPY,treatment_name
IO_THERAPY,treatment_type
IO_TX,treatment_type
IPCHEMO_FIRST_CRS,treatment_type
KINASE_INHIBITOR,treatment_type
LAST_STATUS,vital_status
LAUREN_CLASS,cancer_subtype
LFS_STATUS,vital_status
LINEAGE_SUB_SUBTYPE,cancer_subtype
LINEAGE_SUBTYPE,cancer_subtype
LINES_OF_TX,treatment_number
LINES_OF_TX_PRIOR_IMPACT,treatment_number
LOCALIZED_TUMOR,body_site
LOCALIZED_VS_METS_AT_DX,body_site
LOCATION,body_site
LOCATION_LUNG_PARENCHYMA,body_site
LOCATION_RECURRED,body_site
MAINTENANCE_TX,treatment_reason
MARGINS_INVOLVED_HYSTERECTOMY,treatment_notes
MARGINS_INVOLVED_HYSTERECTOMY,treatment_type
MCRC_TYPE,cancer_subtype
MDS_TYPE,disease
MEDICATION,treatment_name
METASTASECTOMY,treatment_name
METASTASECTOMY,treatment_type
METASTASECTOMY_SITE,treatment_name
METASTASECTOMY_SITE,treatment_notes
METASTASECTOMY_SITE,treatment_type
METASTATIC_RADIATION_THERAPY,treatment_reason
METASTATIC_RADIATION_THERAPY,treatment_type
METASTATIC_SITE,body_site
METS_SITES_AT_METS_ABST_OVARY,sex
METS_SITES_AT_METS_DX_OVARY,sex
MICROTUBULE_TX,treatment_type
MONTHS_ON_TREATMENT,treatment_duration
MORPHOLOGY_SUBTYPE,cancer_subtype
MOST_RECENT_TREATMENT_DURATION,treatment_duration
MOST_RECENT_TREATMENT_DURATION,treatment_reason
MOST_RECENT_TREATMENT_DURATION,treatment_status
MOST_RECENT_TREATMENT_TYPE,treatment_reason
MOST_RECENT_TREATMENT_TYPE,treatment_status
MOST_RECENT_TREATMENT_TYPE,treatment_type
MULTIPLE_TUMOR_LOCATIONS,body_site
MUTATION_PHENOTYPE,cancer_subtype
NEOADJ_CHEMO,treatment_name
NEOADJ_CHEMO,treatment_number
NEOADJ_CHEMO,treatment_reason
NEOADJ_CHEMO,treatment_type
NEOADJ_CHEMOAGENT,treatment_name
NEOADJ_CHEMOAGENT,treatment_reason
NEOADJ_CHEMOAGENT,treatment_type
NEOADJ_CHEMOCYCLES,treatment_number
NEOADJ_CHEMOCYCLES,treatment_reason
NEOADJ_CHEMOCYCLES,treatment_type
NEOADJUVANT,treatment_reason
NEOADJUVANT_CHEMO,treatment_name
NEOADJUVANT_CHEMO,treatment_reason
NEOADJUVANT_CHEMO,treatment_type
NEOADJUVANT_CHEMOTHERAPY,treatment_reason
NEOADJUVANT_CHEMOTHERAPY,treatment_type
NEOADJUVANT_IMMUNOTHERAPY,treatment_reason
NEOADJUVANT_IMMUNOTHERAPY,treatment_type
NEOADJUVANT_TARGETED,treatment_reason
NEOADJUVANT_TARGETED,treatment_type
NEOADJUVANT_THERAPY,treatment_reason
NEOADJUVANT_TREATMENT_DETAILS,treatment_reason
NEOADJUVANT_TREATMENT_DETAILS,treatment_type
NEOADJUVANT_XRT,treatment_reason
NEOADJUVANT_XRT,treatment_type
NGS_PRIOR_THERAPY,treatment_name
NGS_PRIOR_THERAPY,treatment_reason
NONINVASIVE_BLADDER_CA_TX_TYPE,treatment_name
NONINVASIVE_BLADDER_CA_TX_TYPE,treatment_notes
NOREPINEPHRINE,treatment_name
NUCLEOSIDE_TX,treatment_type
NUM_LINES,treatment_notes
NUM_LINES,treatment_number
NUM_LINES_CHEMO,treatment_number
NUM_LINES_CHEMO,treatment_type
NUM_LINES_HORMONE,treatment_number
NUM_LINES_HORMONE,treatment_type
NUM_LINES_IMMUNO,treatment_number
NUM_LINES_IMMUNO,treatment_type
NUM_LINES_IODINE,treatment_name
NUM_LINES_IODINE,treatment_number
NUM_LINES_NTRK,treatment_number
NUM_LINES_NTRK,treatment_type
NUM_LINES_TARGETED,treatment_number
NUM_LINES_TARGETED,treatment_type
NUM_PRIOR_THERAPIES,treatment_status
NUMBER_OF_CYCLES_FLUORO-PYRIMIDINE,treatment_name
NUMBER_OF_CYCLES_FLUORO-PYRIMIDINE,treatment_number
NUMBER_OF_CYCLES_PEMBROLIZUMAB,treatment_name
NUMBER_OF_CYCLES_PEMBROLIZUMAB,treatment_number
NUMBER_OF_CYCLES_PLATINUM,treatment_name
NUMBER_OF_CYCLES_PLATINUM,treatment_number
NUMBER_OF_CYCLES_TRASTUZUMAB,treatment_name
NUMBER_OF_CYCLES_TRASTUZUMAB,treatment_number
NUMBER_OF_LINES_OF_TREATMENT_FOR_MET_DISEASE,treatment_number
NUMBER_OF_PD1_INHIBITOR_INJECTIONS,treatment_number
NUMBER_OF_PD1_INHIBITOR_INJECTIONS,treatment_type
OFF_TREATMENT,treatment_status
ON_TREATMENT,treatment_status
ONGOING_TREATMENT,treatment_status
ORAL_CONTRACEPTION,treatment_duration
ORAL_CONTRACEPTION,treatment_type
ORIGINAL_DIAGNOSIS_AT_IMPLANT,cancer_type
OS_FROM_PD1I_STATUS,vital_status
OS_NEO_STATUS,vital_status
OS_STATUS,vital_status
OS_STATUS_DMT,vital_status
OS_STATUS_IO,vital_status
OS_STATUS_SORAFENIB,vital_status
OTHER_CONCURRENT_THERAPY,treatment_notes
OTHER_CONCURRENT_THERAPY,treatment_status
OTHER_CYTOTOXIC_TX,treatment_notes
OTHER_CYTOTOXIC_TX,treatment_type
OTHER_HYSTERECTOMY_TYPE,treatment_name
OTHER_HYSTERECTOMY_TYPE,treatment_type
OXALIPLATIN_TX,treatment_name
PAM50_SUBTYPE,cancer_subtype
PARTICIPANT_COUNTRY,country
PARTICIPANT_COUNTRY,location
PATHOLOGICAL_DIAGNOSIS,cancer_type
PATHOLOGY_CLASSIFICATION,cancer_subtype
PATIENT_AGE_AT_DIAGNOSIS,age_at_diagnosis
PATIENT_TO_UNDERGO_SURGERY,treatment_type
PD1_INHIBITOR,treatment_name
PD1_INHIBITOR,treatment_type
PD1_INHIBITOR_CONCURRENTLY_WITH_BCNU/CCNU,treatment_name
PD1_INHIBITOR_CONCURRENTLY_WITH_BCNU/CCNU,treatment_status
PD1_INHIBITOR_CONCURRENTLY_WITH_BEV,treatment_name
PD1_INHIBITOR_CONCURRENTLY_WITH_BEV,treatment_status
PD1_INHIBITOR_CONCURRENTLY_WITH_DC_VAX,treatment_name
PD1_INHIBITOR_CONCURRENTLY_WITH_DC_VAX,treatment_status
PD1_INHIBITOR_CONCURRENTLY_WITH_NOVO-TTF,treatment_name
PD1_INHIBITOR_CONCURRENTLY_WITH_NOVO-TTF,treatment_status
PD1_INHIBITOR_CONCURRENTLY_WITH_RE-IRRADIATION,treatment_status
PD1_INHIBITOR_CONCURRENTLY_WITH_RE-IRRADIATION,treatment_type
PD1_INHIBITOR_CONCURRENTLY_WITH_TEMODAR,treatment_name
PD1_INHIBITOR_CONCURRENTLY_WITH_TEMODAR,treatment_status
PD1_INHIBITOR_DRUG,treatment_name
PD1_INHIBITOR_DRUG,treatment_type
PD1_INHIBITOR_STARTED_FOR_PD,treatment_type
PD1_INHIBITOR_WITH_CELECOXIB,treatment_name
PD1_INHIBITOR_WITH_CELECOXIB,treatment_status
PD1_INHIBITOR_WITH_IMATINIB,treatment_name
PD1_INHIBITOR_WITH_IMATINIB,treatment_status
PERSON_NEOPLASM_CANCER_STATUS,cancer_status
PFS_STATUS_IO,vital_status
PFS_STATUS_SORAFENIB_TREATMENT,vital_status
PHARM_TX_MITOTANE_ADJUVANT,treatment_name
PHARM_TX_MITOTANE_ADJUVANT,treatment_reason
PHARM_TX_MITOTANE_ADJUVANT,treatment_type
PHARM_TX_MITOTANE_FOR_MACRO_DISEASE,treatment_name
PHARM_TX_MITOTANE_FOR_MACRO_DISEASE,treatment_reason
PHARM_TX_MITOTANE_FOR_MACRO_DISEASE,treatment_type
PHARM_TX_MITOTANE_INDICATOR,treatment_name
PHARM_TX_MITOTANE_INDICATOR,treatment_type
PHARMACEUTICAL_TX_ADJUVANT,treatment_reason
PHARMACEUTICAL_TX_ADJUVANT,treatment_status
PHARMACEUTICAL_TX_ADJUVANT,treatment_type
PLATINUM_OS_STATUS,vital_status
PLATINUM_TX,treatment_name
POAR_COMBINED_CTLA_PD1,treatment_type
POST_MAPK_TX,treatment_status
POST_MAPK_TX,treatment_type
POST_SAMPLE_CHEMOTHERAPY,treatment_status
POST_SAMPLE_CHEMOTHERAPY,treatment_type
POST_SAMPLE_IMMUNOTHERAPY,treatment_status
POST_SAMPLE_IMMUNOTHERAPY,treatment_type
POST_SAMPLE_TARGETED,treatment_status
POST_SAMPLE_TARGETED,treatment_type
POST_SAMPLE_TX,treatment_status
POST_SAMPLE_XRT,treatment_status
POST_SAMPLE_XRT,treatment_type
POSTOPERATIVE_TX,treatment_reason
POSTOPERATIVE_TX,treatment_status
POSTOPERATIVE_TX,treatment_type
PRD_CHEMOTHERAPY,treatment_notes
PRD_CHEMOTHERAPY,treatment_type
PRD_HISPANIC,ancestry
PRD_HISPANIC,ancestry_details
PRD_HORMONE_THERAPY,treatment_notes
PRD_HORMONE_THERAPY,treatment_type
PRD_OTHER_CANCER_RADIATION,treatment_notes
PRD_OTHER_CANCER_RADIATION,treatment_type
PRD_OTHER_THERAPY,treatment_notes
PRD_OTHER_THERAPY,treatment_type
PRD_PROSTATECTOMY,sex
PRD_PROSTATECTOMY,treatment_name
PRD_PROSTATECTOMY,treatment_notes
PRD_PROSTATECTOMY,treatment_type
PRD_RACE,ancestry
PRD_RACE,ancestry_details
PRD_RADIATION,treatment_notes
PRD_RADIATION,treatment_type
PRD_RADIATION_SURGERY,treatment_notes
PRD_RADIATION_SURGERY,treatment_status
PRD_RADIATION_SURGERY,treatment_type
PRD_SURGERY,treatment_notes
PRD_SURGERY,treatment_type
PRD_TREATED_AT_ENROLLMENT,treatment_notes
PRD_TREATED_AT_ENROLLMENT,treatment_status
PRE_SAMPLE_CHEMOTHERAPY,treatment_status
PRE_SAMPLE_CHEMOTHERAPY,treatment_type
PRE_SAMPLE_IMMUNOTHERAPY,treatment_status
PRE_SAMPLE_IMMUNOTHERAPY,treatment_type
PRE_SAMPLE_TARGETED,treatment_status
PRE_SAMPLE_TARGETED,treatment_type
PRE_SAMPLE_TX,treatment_status
PRE_SAMPLE_XRT,treatment_status
PRE_SAMPLE_XRT,treatment_type
PREDOM_HISTO_SUBTYPE,cancer_subtype
PREDOMINANT_HISTOLOGIC_SUBTYPE,cancer_subtype
PRETREATED,treatment_status
PRETREATMENT_HISTORY,treatment_name
PRETREATMENT_HISTORY,treatment_status
PREVIOUS_MAPKI,treatment_status
PREVIOUS_MAPKI,treatment_type
PREVIOUS_TREATMENT,treatment_name
PREVIOUS_TREATMENT,treatment_reason
PREVIOUS_TREATMENT,treatment_status
PREVIOUS_TREATMENT,treatment_type
PRIMARY_DIAGNOSIS,cancer_type
PRIMARY_MELANOMA_SKIN_TYPE,cancer_subtype
PRIMARY_RADIATION_THERAPY,treatment_status
PRIMARY_RADIATION_THERAPY,treatment_type
PRIMARY_SITE,body_site
PRIMARY_SITE_PATIENT,body_site
PRIMARY_SURGERY,treatment_name
PRIMARY_SURGERY,treatment_status
PRIMARY_SURGERY,treatment_type
PRIMARY_TUMOR_LOCALIZATION_TYPE,cancer_subtype
PRIMARY_TUMOR_LOCATION,body_site
PRIMARY_TYPE,cancer_subtype
PRIOR_ADJUVANT_CHEMO,treatment_reason
PRIOR_ADJUVANT_CHEMO,treatment_type
PRIOR_INTRAVESICAL_CHEMOTHERAPY,treatment_name
PRIOR_INTRAVESICAL_CHEMOTHERAPY,treatment_status
PRIOR_INTRAVESICAL_CHEMOTHERAPY,treatment_type
PRIOR_LINES,treatment_number
PRIOR_LINES,treatment_status
PRIOR_LINES_OF_THERAPY,treatment_number
PRIOR_LINES_OF_THERAPY,treatment_status
PRIOR_MALIGNANCY_RADIATION_TX,treatment_type
PRIOR_MAPK_TX,treatment_status
PRIOR_MAPK_TX,treatment_type
PRIOR_SYSTEMIC_THERAPIES,treatment_status
PRIOR_SYSTEMIC_THERAPIES,treatment_type
PRIOR_THERAPY,treatment_status
PRIOR_TREATMENT,treatment_dose
PRIOR_TREATMENT,treatment_duration
PRIOR_TREATMENT,treatment_name
PRIOR_TREATMENT,treatment_notes
PRIOR_TREATMENT,treatment_number
PRIOR_TREATMENT,treatment_reason
PRIOR_TREATMENT,treatment_status
PRIOR_TREATMENT,treatment_type
PRIOR_TREATMENT_OF_CYTOTOXIC_CHEMOTHERAPY,treatment_status
PRIOR_TREATMENT_OF_CYTOTOXIC_CHEMOTHERAPY,treatment_type
PRIOR_TX_TO_IMPACT_SAMPLE,treatment_type
PRIORRADIATIONFOROTHERCANCER,treatment_reason
PRIORRADIATIONFOROTHERCANCER,treatment_status
PRIORRADIATIONFOROTHERCANCER,treatment_type
PROCEDURE,treatment_notes
PROCEDURE,treatment_type
PROCEDURE_TYPE,treatment_name
PROCEDURE_TYPE,treatment_type
PROTOCOL_AND_TREATMENT_ARM,treatment_group
PROTOCOL_AND_TREATMENT_ARM,treatment_name
R_CHOP_LIKE_CHEMO,treatment_type
RACE,ancestry
RACE,ancestry_details
RACE_CATEGORIZED,ancestry
RACE_CATEGORIZED,ancestry_details
RACE_CATEGORY,ancestry
RACE_CATEGORY,ancestry_details
RADADJUVANTRX,treatment_name
RADADJUVANTRX,treatment_reason
RADADJUVANTRX,treatment_type
RADIATION,treatment_type
RADIATION_DOSE,treatment_dose
RADIATION_DOSE,treatment_type
RADIATION_DOSE_PELVIC_NODES_PRIMARY_TUMOR.,treatment_dose
RADIATION_DOSE_PELVIC_NODES_PRIMARY_TUMOR.,treatment_type
RADIATION_OR_CHEMOTHERAPY,treatment_type
RADIATION_OTHER,treatment_name
RADIATION_OTHER,treatment_type
RADIATION_SITE,treatment_notes
RADIATION_SITE,treatment_type
RADIATION_THERAPY,treatment_type
RADIATION_THERAPY_DOSE_PARAAORTIC_NODES,treatment_dose
RADIATION_THERAPY_DOSE_PARAAORTIC_NODES,treatment_reason
RADIATION_THERAPY_DOSE_PARAAORTIC_NODES,treatment_type
RADIATION_THERAPY_XRT_TYPE,treatment_notes
RADIATION_THERAPY_XRT_TYPE,treatment_type
RADIATION_TREATMENT_ADJUVANT,treatment_name
RADIATION_TREATMENT_ADJUVANT,treatment_reason
RADIATION_TREATMENT_ADJUVANT,treatment_status
RADIATION_TREATMENT_ADJUVANT,treatment_type
RADIATION_TYPE,treatment_notes
RADIATION_TYPE,treatment_type
RADIATION_TYPE_OTHER,treatment_notes
RADIATION_TYPE_OTHER,treatment_type
RADIO_THERAPY,treatment_type
RADIOTHERAPY,treatment_type
RADIOTHERAPY_FRACTIONS,treatment_number
RADIOTHERAPY_FRACTIONS,treatment_type
RADIOTHERAPY_TX,treatment_type
REASON_FOR_TX_DISCONTINUATION,treatment_notes
RECEIVED_IO_AFTER_1ST_LINE,treatment_status
RECEIVED_IO_AFTER_1ST_LINE,treatment_type
RECEIVED_TARGETED_TX,treatment_type
REPORTED_ETHNICITY,ancestry
REPORTED_ETHNICITY,ancestry_details
RESIDUAL_NODAL_DISEASE,disease
RFS_STATUS,vital_status
RT_TX_REASON_NOT_COMPLETED,treatment_notes
RT_TX_REASON_NOT_COMPLETED,treatment_reason
RT_TX_REASON_NOT_COMPLETED,treatment_status
RT_TX_REASON_NOT_COMPLETED,treatment_type
RT_TX_REASON_NOT_COMPLETED_OTHER,treatment_notes
RT_TX_REASON_NOT_COMPLETED_OTHER,treatment_reason
RT_TX_REASON_NOT_COMPLETED_OTHER,treatment_status
RT_TX_REASON_NOT_COMPLETED_OTHER,treatment_type
RT_TX_TOTAL_DOSE_TO_PELVIS,treatment_dose
RT_TX_TOTAL_DOSE_TO_PELVIS,treatment_reason
RT_TX_TOTAL_DOSE_TO_PELVIS,treatment_status
RT_TX_TOTAL_DOSE_TO_PELVIS,treatment_type
SALICYLATES,treatment_type
SALVAGE_CHEMO,treatment_reason
SALVAGE_CHEMO,treatment_type
SAMPLE_CLASS,sample_type
SAMPLE_CLASS,specimen_type
SAMPLE_TYPE,sample_type
SAMPLE_TYPE,specimen_type
SECOND_LINE_TC_OR_SURGERY,treatment_name
SECOND_LINE_TC_OR_SURGERY,treatment_number
SECOND_LINE_TC_OR_SURGERY,treatment_reason
SECOND_LINE_TC_OR_SURGERY,treatment_type
SEX,sex
SORAFENIB_TREATMENT,treatment_name
SOURCE_TYPE,body_site
SPECIAL_HISTOLOGY,cancer_type_details
SPECIFIC_DX_AT_ACQUISITION_MDSMPN,cancer_type
SPECIFIC_DX_AT_INCLUSION,disease
SPECIFIC_TUMOR_LOCATION,body_site
SPECIMEN_TYPE,sample_type
SPECIMEN_TYPE,specimen_type
STATUS,vital_status
STEROIDS,treatment_type
STEROIDS_GT_10MG_DAILY,treatment_dose
STEROIDS_GT_10MG_DAILY,treatment_frequency
STEROIDS_GT_10MG_DAILY,treatment_name
STEROIDS_GT_10MG_DAILY,treatment_type
STEROIDS_WHEN_STARTED_PD1_INHIBITOR,treatment_type
STREOIDS_DURING_PD1_INHIBITOR,treatment_status
STREOIDS_DURING_PD1_INHIBITOR,treatment_type
SUBSEQUENT_RX,treatment_dose
SUBSEQUENT_RX,treatment_name
SUBSEQUENT_RX,treatment_number
SUBSEQUENT_RX,treatment_reason
SUBSEQUENT_RX,treatment_type
SUBTYPE,cancer_subtype
SUBTYPE_ABBREVIATION,cancer_subtype
SUBTYPE_CONSENSUS,cancer_subtype
SUBTYPE_DETAILS,cancer_subtype
SUBTYPE_GROUP,cancer_subtype
SURGERY,treatment_name
SURGERY,treatment_type
SURGERY NUMBER,treatment_number
SURGERY NUMBER,treatment_type
SURGERY_ADVANCED_DISEASE,treatment_status
SURGERY_ADVANCED_DISEASE,treatment_type
SURGERY_AT_DX,treatment_name
SURGERY_AT_DX,treatment_reason
SURGERY_AT_DX,treatment_status
SURGERY_AT_DX,treatment_type
SURGERY_DATE_RELATIVE_TO_DX_MONTHS,treatment_duration
SURGERY_DATE_RELATIVE_TO_DX_MONTHS,treatment_notes
SURGERY_DATE_RELATIVE_TO_DX_MONTHS,treatment_type
SURGERY_FOR_POSITIVE_MARGINS,treatment_name
SURGERY_FOR_POSITIVE_MARGINS,treatment_type
SURGERY_FOR_POSITIVE_MARGINS_OTHER,treatment_name
SURGERY_FOR_POSITIVE_MARGINS_OTHER,treatment_type
SURGERY_INDICATION,treatment_reason
SURGERY_INDICATION,treatment_type
SURGERY_PROCEDURE,treatment_name
SURGERY_PROCEDURE,treatment_type
SURGERY_TYPE,treatment_name
SURGERY_TYPE,treatment_notes
SURGERY_TYPE,treatment_type
SURGICAL_APPROACH_AT_DIAGNOSIS,treatment_notes
SURGICAL_APPROACH_AT_DIAGNOSIS,treatment_status
SURGICAL_APPROACH_AT_DIAGNOSIS,treatment_type
SURGICAL_PROCEDURE_FIRST,treatment_name
SURGICAL_PROCEDURE_FIRST,treatment_status
SURGICAL_PROCEDURE_FIRST,treatment_type
SURVIVAL_STATUS,vital_status
SYSTEMIC_CHEMO,treatment_type
SYSTEMIC_THERAPY,treatment_type
SYSTEMIC_TREATMENT,treatment_name
SYSTEMIC_TREATMENT,treatment_type
TARGET_THERAPY,treatment_type
TARGETED_MOLECULAR_THERAPY,treatment_type
TARGETED_THERAPY,treatment_type
TARGETED_TX,treatment_type
TAXANE_TX,treatment_type
TERT_ALKYLATING_TX,treatment_type
TERT_ANTHRACYCLINE_TX,treatment_name
TERT_ANTIMETABOLITE_TX,treatment_type
TERT_CARBOLATIN_TX,treatment_name
TERT_CISPLATIN_TX,treatment_name
TERT_CYTOTOXIC_TX,treatment_type
TERT_IO_TX,treatment_type
TERT_MICROTUBULE_TX,treatment_type
TERT_OTHER_CYTOTOXIC_TX,treatment_notes
TERT_OTHER_CYTOTOXIC_TX,treatment_type
TERT_OXALIPLATIN_TX,treatment_name
TERT_PLATINUM_TX,treatment_name
TERT_TARGETED_TX,treatment_type
TERT_TAXANE_TX,treatment_type
TERT_TOPO_I_INH_TX,treatment_name
TERT_TOPO_II_INH_TX,treatment_name
TESTES_SITE_OF_RELAPSE,sex
TESTICULAR_INVOLVEMENT,sex
TESTIS_TUMOR_MACROEXTENT,sex
THERAPIES,treatment_type
THERAPY,treatment_name
THERAPY,treatment_type
THERAPY_PRIOR_TO_DERIVATION,treatment_name
THERAPY_PRIOR_TO_DERIVATION,treatment_status
THIRD_LINE,treatment_dose
THIRD_LINE,treatment_name
THIRD_LINE,treatment_number
THIRD_LINE,treatment_reason
THIRD_LINE,treatment_type
TIMING_OTHER_NOTES,treatment_end
TIMING_OTHER_NOTES,treatment_frequency
TIMING_OTHER_NOTES,treatment_name
TIMING_OTHER_NOTES,treatment_notes
TISSUE_SITE,body_site
TISSUE_SITE_OF_DERIVATION,body_site
TISSUE_TYPE,body_site
TKI_TREATMENT,treatment_type
TMZ_CYCLES,treatment_name
TMZ_CYCLES,treatment_number
TMZ_TREATMENT,treatment_name
TOPO_I_TX,treatment_name
TOPO_II_TX,treatment_name
TOTAL_CYCLES_NUM_NEOADJUVANT_ADJUVANT,treatment_notes
TOTAL_CYCLES_NUM_NEOADJUVANT_ADJUVANT,treatment_number
TOTAL_CYCLES_NUM_NEOADJUVANT_ADJUVANT,treatment_reason
TOTAL_TIME_PERIOD_MONTHS,treatment_duration
TRANSPLANT_TYPE,treatment_name
TRANSPLANT_TYPE,treatment_type
TREATED_WITH_ICI,treatment_type
TREATMENT,treatment_name
TREATMENT,treatment_status
TREATMENT,treatment_type
TREATMENT_ARM,treatment_group
TREATMENT_AT_MSK,treatment_notes
TREATMENT_CATEGORY,treatment_type
TREATMENT_CHANGED,treatment_status
TREATMENT_CHEMOTHERAPY,treatment_type
TREATMENT_DETAIL_BEFORE_PDX,treatment_name
TREATMENT_DETAILS,treatment_name
TREATMENT_DETAILS,treatment_number
TREATMENT_GROUP,treatment_dose
TREATMENT_GROUP,treatment_group
TREATMENT_GROUP,treatment_reason
TREATMENT_HORMONE_THERAPY,treatment_type
TREATMENT_ONGOING,treatment_status
TREATMENT_PALLIATIVE_RADIATION,treatment_reason
TREATMENT_PALLIATIVE_RADIATION,treatment_type
TREATMENT_PRIOR_TO_RESECTION,treatment_status
TREATMENT_PRIOR_TO_RESECTION,treatment_type
TREATMENT_PRIOR_TO_SURGERY_INDICATOR,treatment_name
TREATMENT_PRIOR_TO_SURGERY_INDICATOR,treatment_status
TREATMENT_PRIOR_TO_SURGERY_INDICATOR,treatment_type
TREATMENT_PROSTATECTOMY,treatment_name
TREATMENT_PROSTATECTOMY,treatment_type
TREATMENT_RADIATION,treatment_type
TREATMENT_SCHEDULE,treatment_frequency
TREATMENT_STATUS,treatment_status
TREATMENT_TYPE,treatment_name
TREATMENT_TYPE,treatment_type
TUMOR_LATERALITY,body_site
TUMOR_LEVEL,body_site
TUMOR_LOCATION,body_site
TUMOR_LOCATION_CONDENSED,body_site
TUMOR_MEGASITE,body_site
TUMOR_SAMPLE_PROCUREMENT_COUNTRY,country
TUMOR_SAMPLE_PROCUREMENT_COUNTRY,location
TUMOR_SITE,body_site
TUMOR_SITE_CURATED,body_site
TUMOR_SITE_DETAIL,body_site
TUMOR_SITE_SAMPLE,body_site
TUMOR_SUBSITE,body_site
TUMOR_SUPERSITE,body_site
TUMOR_SURGERY_NUMBER,treatment_reason
TUMOR_SURGERY_NUMBER,treatment_type
TUMOR_TISSUE_ORIGIN,body_site
TUMOR_TISSUE_SITE,body_site
TUMOR_TISSUE_SITE_PATIENT,body_site
TX_17-DMAG,treatment_name
TX_19D12,treatment_name
TX_90DAYS_POST_RESECTION,treatment_start
TX_90DAYS_POST_RESECTION,treatment_status
TX_ABRAXANE,treatment_name
TX_ABT-199,treatment_name
TX_ABT-263,treatment_name
TX_ACTINOMYCIN D,treatment_name
TX_APLIDIN,treatment_name
TX_AZD-2171,treatment_name
TX_AZD-6244,treatment_name
TX_AZD1480,treatment_name
TX_AZD8055,treatment_name
TX_BAL101553,treatment_name
TX_BET_PRI_MET_SAMPLE_COLLECTION,treatment_type
TX_BI6727 (VOLASERTIB),treatment_name
TX_BMN-673,treatment_name
TX_BMS-354825,treatment_name
TX_BMS-754807,treatment_name
TX_BORTEZOMIB,treatment_name
TX_CABOZANTINIB (XL-148),treatment_name
TX_CBL0137,treatment_name
TX_CDX-011 (GLEMBATUMUMAB),treatment_name
TX_CGC(PG)-11047,treatment_name
TX_CISPLATIN,treatment_name
TX_CPX351,treatment_name
TX_CX-5461 (POL1),treatment_name
TX_CYCLOPHOSPHAMIDE,treatment_name
TX_CYTARABINE,treatment_name
TX_E7438/EPZ6438,treatment_name
TX_EC1456,treatment_name
TX_ERIBULIN,treatment_name
TX_FENRETINIDE,treatment_name
TX_GENZ-644282,treatment_name
TX_GS-9820,treatment_name
TX_GSK690693,treatment_name
TX_GSK923295A,treatment_name
TX_HGS-ETR1,treatment_name
TX_IMC-A12,treatment_name
TX_INDUCTION_COURSES_INDICATOR,treatment_reason
TX_INK128-1110-028,treatment_name
TX_JNJ26481585,treatment_name
TX_JNJ26854165,treatment_name
TX_KPT-330,treatment_name
TX_LAPATINIB,treatment_name
TX_LENOLIDAMIDE,treatment_name
TX_LINE,treatment_reason
TX_LOCATION,treatment_notes
TX_LY 2606368,treatment_name
TX_MAINTENANCE_COURSES_INDICATOR,treatment_reason
TX_MK-2206,treatment_name
TX_MK-8242,treatment_name
TX_MLN4924,treatment_name
TX_MLN8237,treatment_name
TX_MM-141,treatment_name
TX_NSC750854,treatment_name
TX_PCI-32765,treatment_name
TX_PF-03084014,treatment_name
TX_PIXANTRONE,treatment_name
TX_PR-104,treatment_name
TX_RAPAMYCIN,treatment_name
TX_REG,treatment_name
TX_RG7112,treatment_name
TX_RO4929097,treatment_name
TX_RUXOLITINIB,treatment_name
TX_SAHA,treatment_name
TX_SAR3419,treatment_name
TX_SB-715992,treatment_name
TX_SCH 727965,treatment_name
TX_SETTING,treatment_reason
TX_SGI-1776,treatment_name
TX_SGN-CD19A,treatment_name
TX_SORAFENIB,treatment_name
TX_STA9090 (GANETESPIB),treatment_name
TX_STF-118804,treatment_name
TX_SU11248,treatment_name
TX_SVV-001,treatment_name
TX_TAK-701,treatment_name
TX_TB-403,treatment_name
TX_TL32711,treatment_name
TX_TOPOTECAN,treatment_name
TX_TRISENOX(ATO),treatment_name
TX_VINCRISTINE,treatment_name
TX_VS-4718,treatment_name
TX_XL147,treatment_name
TYPE,cancer_subtype
TYPE_INDUCTION_TREATMENT,treatment_reason
TYPE_INDUCTION_TREATMENT,treatment_type
TYPE_INDUCTION_TX,treatment_reason
TYPE_INDUCTION_TX,treatment_status
TYPE_INDUCTION_TX,treatment_type
TYPE_OF_SURGERY,treatment_name
TYPE_OF_SURGERY,treatment_reason
TYPE_OF_SURGERY,treatment_type
TYPE_REFINED,cancer_subtype
UV_RATE,treatment_dose
UV_RATE,treatment_type
VITAL_STATUS,vital_status
WEEKS_ON_STUDY,treatment_duration
WEEKS_ON_TREATMENT,treatment_duration
WHO_CLASS,disease
WHO_CLASSIFICATION,disease
X2YR_AIS,treatment_duration
X2YR_AIS,treatment_name
X2YR_ALKYLATING_AGENT,treatment_duration
X2YR_ALKYLATING_AGENT,treatment_type
X2YR_ANTHRACYCLINE,treatment_duration
X2YR_ANTHRACYCLINE,treatment_name
X2YR_ANTIHER2,treatment_duration
X2YR_ANTIHER2,treatment_name
X2YR_CAPECITABINE,treatment_duration
X2YR_CAPECITABINE,treatment_name
X2YR_CDK46,treatment_duration
X2YR_CDK46,treatment_name
X2YR_FULVESTRANT,treatment_duration
X2YR_FULVESTRANT,treatment_name
X2YR_TAMOXIFEN,treatment_duration
X2YR_TAMOXIFEN,treatment_name
X2YR_TAXANE,treatment_duration
X2YR_TAXANE,treatment_type
X2YR_VEGF_INHIBITOR,treatment_duration
X2YR_VEGF_INHIBITOR,treatment_type
XRT_TX,treatment_type
YEAR_OF_SURGERY,treatment_start
YEAR_OF_SURGERY,treatment_type
